HDAC inhibition prevents transgene expression downregulation and loss-of-function in T cell-receptor-transduced T cells is a research paper published in Molecular Therapy — Oncolytics (2021). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P01CA154778
National Institutes of Health
Grant: R01CA90873
National Institutes of Health
Grant: R01CA104947
National Institutes of Health
Grant: R01AI129543-01
NHLBI NIH HHS
Grant: T35 HL120835
NIAID NIH HHS
Grant: R01 AI129543
NCI NIH HHS
Grant: R01 CA090873
National Institutes of Health
Grant: 1R01CA090873-01
Tumor Recognition by TCR Transduced CD4+ and CD8+T Cells
National Institutes of Health
Grant: 3R01CA104947-03S1
TCR Affinity and Therapeutic Efficacy of T Cells
National Institutes of Health
Grant: 5R01AI129543-05
Building better T cell receptors for targeted immunotherapy
National Institutes of Health
Grant: 5P01CA154778-04
CLINICAL TRIALS USING TCR TRANSDUCED T CELL FOR ADOPTIVE IMMUNOTHERAPY
Merck
National Cancer Institute
FWCI
0.65
Citation Percentile
0.7%
Influential Citations
1
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals